1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Digital Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Digital Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Digital Therapeutics Market Regional Analysis
6.2 North America Digital Therapeutics Market Revenue 2019-2028 (US$ Million)
6.3 North America Digital Therapeutics Market Forecast Analysis
7. North America Digital Therapeutics Market Analysis – by Application
7.1 Diabetes
- 7.1.1 Overview
- 7.1.2 Diabetes: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Cardiovascular Diseases
- 7.2.1 Overview
- 7.2.2 Cardiovascular Diseases: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Central Nervous System Disease
- 7.3.1 Overview
- 7.3.2 Central Nervous System Disease: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Respiratory Diseases
- 7.4.1 Overview
- 7.4.2 Respiratory Diseases: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Smoking Cessation
- 7.5.1 Overview
- 7.5.2 Smoking Cessation: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Musculoskeletal Diseases
- 7.6.1 Overview
- 7.6.2 Musculoskeletal Diseases: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Digital Therapeutics Market Analysis – by Distribution Channel
8.1 Patients
- 8.1.1 Overview
- 8.1.2 Patients: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Providers
- 8.2.1 Overview
- 8.2.2 Providers: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Payers
- 8.3.1 Overview
- 8.3.2 Payers: North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Employers
- 8.4.1 Overview
- 8.4.2 Employers : North America Digital Therapeutics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Digital Therapeutics Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Digital Therapeutics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 North America Digital Therapeutics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Digital Therapeutics Market Breakdown, by Application
- 9.2.1.1.2 US: North America Digital Therapeutics Market Breakdown, by Distribution Channel
- 9.2.1.2 Canada:
North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Digital Therapeutics Market Breakdown, by Application
- 9.2.1.2.2 Canada: North America Digital Therapeutics Market Breakdown, by Distribution Channel
- 9.2.1.3 Mexico :
North America Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Digital Therapeutics Market Breakdown, by Application
- 9.2.1.3.2 Mexico : North America Digital Therapeutics Market Breakdown, by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Propeller Health (ResMed)
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Canary Health
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Noom, Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 2Morrow, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teladoc Health, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Welldoc, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fitbit, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Omada Health, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 MANGO HEALTH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Pear Therapeutics, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Digital Therapeutics Market
